EIT Pharma (Series A)
Funding Details
Awarder
Inbox
Date Award
September 3, 2026
Vertical
Biotechnology
Funding Amount
$35,000,000
Company Info
Founders
Leen Kawas
Market
Infectious Diseases
Location
Kirkland, WA, USA
Coinvestors
Arrowtown, Good Ventures, Propel Bio Partners
Company Description

EIT Pharma is a biotechnology company focused on advancing therapies for infectious diseases with significant unmet medical needs. The company is developing a portfolio of programs designed to address serious infectious diseases through rigorous science, disciplined execution, and a patient-centered approach focused on translating scientific innovation into meaningful real-world impact for patients.

Links